Published in Trends Immunol on September 29, 2011
Pathways of antigen processing. Annu Rev Immunol (2013) 2.82
Ribosome profiling reveals pervasive translation outside of annotated protein-coding genes. Cell Rep (2014) 2.04
Kinetics of antigen expression and epitope presentation during virus infection. PLoS Pathog (2013) 1.21
The human leukocyte antigen-presented ligandome of B lymphocytes. Mol Cell Proteomics (2013) 1.13
Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation. Mol Cell Proteomics (2015) 1.08
Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides. Nat Commun (2014) 1.01
Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters. Proc Natl Acad Sci U S A (2012) 1.01
Presentation of phagocytosed antigens by MHC class I and II. Traffic (2012) 0.98
Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors. J Leukoc Biol (2014) 0.97
Re-examining class-I presentation and the DRiP hypothesis. Trends Immunol (2014) 0.97
Understanding the biology of antigen cross-presentation for the design of vaccines against cancer. Front Immunol (2014) 0.93
The nature and extent of contributions by defective ribosome products to the HLA peptidome. Proc Natl Acad Sci U S A (2014) 0.92
Pathways to Specialized Ribosomes: The Brussels Lecture. J Mol Biol (2016) 0.91
The effect of proteasome inhibition on the generation of the human leukocyte antigen (HLA) peptidome. Mol Cell Proteomics (2013) 0.89
Monitoring peptide processing for MHC class I molecules in the endoplasmic reticulum. Curr Opin Immunol (2013) 0.86
Proteome sampling by the HLA class I antigen processing pathway. PLoS Comput Biol (2012) 0.85
Substrate-induced protein stabilization reveals a predominant contribution from mature proteins to peptides presented on MHC class I. J Immunol (2013) 0.85
Translation quality control is critical for bacterial responses to amino acid stress. Proc Natl Acad Sci U S A (2016) 0.85
Processing of recombinant Listeria monocytogenes proteins for MHC class I presentation follows a dedicated, high-efficiency pathway. J Immunol (2013) 0.84
Dysfunction in protein clearance by the proteasome: impact on autoinflammatory diseases. Semin Immunopathol (2015) 0.84
Positional bias of MHC class I restricted T-cell epitopes in viral antigens is likely due to a bias in conservation. PLoS Comput Biol (2013) 0.82
Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals. Eur J Immunol (2014) 0.82
Present Yourself! By MHC Class I and MHC Class II Molecules. Trends Immunol (2016) 0.81
Receptor Pre-Clustering and T cell Responses: Insights into Molecular Mechanisms. Front Immunol (2014) 0.80
UBQLN4 recognizes mislocalized transmembrane domain proteins and targets these to proteasomal degradation. EMBO Rep (2016) 0.79
Peptidases released by necrotic cells control CD8+ T cell cross-priming. J Clin Invest (2013) 0.79
Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers. Leukemia (2016) 0.78
Defining the expression hierarchy of latent T-cell epitopes in Epstein-Barr virus infection with TCR-like antibodies. Sci Rep (2013) 0.78
Linkage of bacterial protein synthesis and presentation of MHC class I-restricted Listeria monocytogenes-derived antigenic peptides. PLoS One (2012) 0.78
Nuclear translation for immunosurveillance. Proc Natl Acad Sci U S A (2013) 0.78
A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus. Dis Model Mech (2014) 0.77
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction. Immunity (2017) 0.77
Nucleocytoplasmic shuttling and CRM1-dependent MHC class I peptide presentation of human cytomegalovirus pp65. Med Microbiol Immunol (2012) 0.77
The same major histocompatibility complex polymorphism involved in control of HIV influences peptide binding in the mouse H-2Ld system. J Biol Chem (2013) 0.77
In situ loading of skin dendritic cells with apoptotic bleb-derived antigens for the induction of tumor-directed immunity. Oncoimmunology (2014) 0.77
Going Pro to enhance T-cell immunogenicity: easy as π? Eur J Immunol (2013) 0.76
Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection. Infect Immun (2015) 0.76
Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells. J Virol (2016) 0.76
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015. J Transl Med (2016) 0.76
Presentation of Cryptic Peptides by MHC Class I Is Enhanced by Inflammatory Stimuli. J Immunol (2016) 0.75
Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function. PLoS Pathog (2016) 0.75
Editorial: Proteostenosis: cancer's Achilles heel? J Leukoc Biol (2012) 0.75
Antigenic peptides: Reviving nuclear translation. Nat Chem Biol (2013) 0.75
Granulostasis: Protein Quality Control of RNP Granules. Front Mol Neurosci (2017) 0.75
Exosome-driven transfer of tumor-associated Pioneer Translation Products (TA-PTPs) for the MHC class I cross-presentation pathway. Oncoimmunology (2016) 0.75
A novel influenza A virus mitochondrial protein that induces cell death. Nat Med (2001) 9.90
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature (2000) 7.10
Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity (1997) 5.44
Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell (1985) 5.25
Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function. Genes Dev (2007) 4.97
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med (2006) 4.84
Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell (2010) 4.45
ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature (2003) 4.18
Global protein stability profiling in mammalian cells. Science (2008) 3.91
Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science (2007) 3.27
Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity (2003) 3.14
Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol (2008) 3.08
Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immunol (2003) 3.00
Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity (2000) 2.94
Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? J Immunol (1996) 2.88
Protein turnover in mammaliar cell cultures. J Biol Chem (1959) 2.85
Interphase nuclei of many mammalian cell types contain deep, dynamic, tubular membrane-bound invaginations of the nuclear envelope. J Cell Biol (1997) 2.82
Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol (2009) 2.80
The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature (2000) 2.70
Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science (1988) 2.59
Innate immune and chemically triggered oxidative stress modifies translational fidelity. Nature (2009) 2.50
Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J Exp Med (1991) 2.48
Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science (2003) 2.46
Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence. Nature (1987) 2.44
The DRiP hypothesis decennial: support, controversy, refinement and extension. Trends Immunol (2006) 2.42
Protein synthesis upon acute nutrient restriction relies on proteasome function. Science (2005) 2.32
Misfolded proteins impose a dosage-dependent fitness cost and trigger a cytosolic unfolded protein response in yeast. Proc Natl Acad Sci U S A (2010) 2.23
Protein degradation in cultured cells. The effect of fresh medium, fluoride, and iodoacetate on the digestion of cellular protein of rat fibroblasts. J Biol Chem (1973) 2.23
MHC class I: an unexpected role in neuronal plasticity. Neuron (2009) 2.20
Intracellular localization of proteasomal degradation of a viral antigen. J Cell Biol (1999) 2.04
Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity (2003) 1.89
Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J Exp Med (1996) 1.86
Constitutive display of cryptic translation products by MHC class I molecules. Science (2003) 1.67
The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem J (2010) 1.65
Characterization of rapidly degraded polypeptides in mammalian cells reveals a novel layer of nascent protein quality control. J Biol Chem (2005) 1.62
RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes. J Exp Med (1992) 1.52
Signal sequence- and translation-independent mRNA localization to the endoplasmic reticulum. RNA (2008) 1.49
Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames. J Exp Med (2004) 1.48
Plumbing the sources of endogenous MHC class I peptide ligands. Curr Opin Immunol (2006) 1.47
AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape. J Exp Med (2007) 1.47
BAG-6 is essential for selective elimination of defective proteasomal substrates. J Cell Biol (2010) 1.46
MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J Immunol (1997) 1.44
Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein. J Immunol (2001) 1.44
Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation. Proc Natl Acad Sci U S A (2011) 1.40
Fluorescent proteins: a cell biologist's user guide. Trends Cell Biol (2009) 1.40
A porcine model for initial surge mechanical ventilator assessment and evaluation of two limited-function ventilators. Crit Care Med (2011) 1.39
Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J Exp Med (1996) 1.39
Regulation of translation is required for dendritic cell function and survival during activation. J Cell Biol (2007) 1.34
The turnover kinetics of major histocompatibility complex peptides of human cancer cells. Mol Cell Proteomics (2005) 1.33
The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. Immunity (2008) 1.30
Unanticipated antigens: translation initiation at CUG with leucine. PLoS Biol (2004) 1.29
Biology of simian virus 40 (SV40) transplantation antigen (TrAg). IX. Analysis of TrAg in mouse cells synthesizing truncated SV40 large T antigen. Virology (1983) 1.28
Analysis of mRNA partitioning between the cytosol and endoplasmic reticulum compartments of mammalian cells. Methods Mol Biol (2008) 1.28
Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition. Proc Natl Acad Sci U S A (2008) 1.28
Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products. J Immunol (2006) 1.27
Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing. Trends Cell Biol (2001) 1.27
A distinct translation initiation mechanism generates cryptic peptides for immune surveillance. PLoS One (2008) 1.26
Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface. Mol Cell Proteomics (2006) 1.26
Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J Exp Med (1997) 1.25
Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action. Proc Natl Acad Sci U S A (2010) 1.25
Post-translational modifications of naturally processed MHC-binding epitopes. Curr Opin Immunol (2005) 1.24
The seven dirty little secrets of major histocompatibility complex class I antigen processing. Immunol Rev (2005) 1.23
Does protein synthesis occur in the nucleus? Curr Opin Cell Biol (2004) 1.22
Stable ribosome binding to the endoplasmic reticulum enables compartment-specific regulation of mRNA translation. Mol Biol Cell (2005) 1.21
Kinetics of degradation of "short-" and "long-lived" proteins in cultured mammalian cells. Cell Biol Int Rep (1980) 1.20
Soluble plasma HLA peptidome as a potential source for cancer biomarkers. Proc Natl Acad Sci U S A (2010) 1.18
Genes coding for T-cell-defined tum transplantation antigens: point mutations, antigenic peptides, and subgenic expression. Cold Spring Harb Symp Quant Biol (1989) 1.15
The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J Exp Med (1998) 1.14
Alternative translational products and cryptic T cell epitopes: expecting the unexpected. J Immunol (2006) 1.14
A Genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation. Cell (2011) 1.14
Visualizing high error levels during gene expression in living bacterial cells. Proc Natl Acad Sci U S A (2010) 1.11
Out with the old, in with the new? Comparing methods for measuring protein degradation. Cell Biol Int (2011) 1.09
Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance. J Immunol (2011) 1.09
Alternative pathways for MHC class I presentation: a new function for autophagy. Cell Mol Life Sci (2011) 1.08
Gly-Ala repeats induce position- and substrate-specific regulation of 26 S proteasome-dependent partial processing. J Biol Chem (2008) 1.08
A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains. Eur J Immunol (2000) 1.06
Understanding GFP posttranslational chemistry: structures of designed variants that achieve backbone fragmentation, hydrolysis, and decarboxylation. J Am Chem Soc (2006) 1.06
Rethinking peptide supply to MHC class I molecules. Nat Rev Immunol (2007) 1.05
To DRiP or not to DRiP: generating peptide ligands for MHC class I molecules from biosynthesized proteins. Mol Immunol (2002) 1.05
RNA polymerase II inhibitors dissociate antigenic peptide generation from normal viral protein synthesis: a role for nuclear translation in defective ribosomal product synthesis? J Immunol (2010) 1.05
At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules. J Cell Sci (2001) 1.04
Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport. J Immunol (2003) 1.04
mTORC1 links protein quality and quantity control by sensing chaperone availability. J Biol Chem (2010) 1.04
The synthesis of truncated polypeptides for immune surveillance and viral evasion. PLoS One (2010) 1.04
Defective ribosomal products are the major source of antigenic peptides endogenously generated from influenza A virus neuraminidase. J Immunol (2009) 1.02
Regulated folding of tyrosinase in the endoplasmic reticulum demonstrates that misfolded full-length proteins are efficient substrates for class I processing and presentation. J Immunol (2005) 1.01
Viral alteration of cellular translational machinery increases defective ribosomal products. J Virol (2007) 1.00
A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes. J Immunol (1991) 0.98
Cutting edge: MHC class I-Ly49 interaction regulates neuronal function. J Immunol (2008) 0.97
Cross-priming utilizes antigen not available to the direct presentation pathway. Immunology (2006) 0.97
Systematic search fails to detect immunogenic MHC class-I-restricted determinants encoded by influenza A virus noncoding sequences. Virology (2003) 0.96
Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses. Proc Natl Acad Sci U S A (2009) 0.95
T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display. PLoS Pathog (2009) 0.94
Generating MHC class I ligands from viral gene products. Immunol Rev (1999) 0.94
Major histocompatibility class I molecules can present cryptic translation products to T-cells. J Biol Chem (1995) 0.94
Direct visualization of the dynamics of antigen presentation in human cells infected with cytomegalovirus revealed by antibodies mimicking TCR specificity. Eur J Immunol (2010) 0.93
The case for nuclear translation. J Cell Sci (2004) 0.93
Viva la revolución: rethinking influenza a virus antigenic drift. Curr Opin Virol (2011) 1.02
Greasing the SCIDs for universal flu antibodies. Cell Host Microbe (2013) 0.75
Amsterdamming DRiPs. Mol Immunol (2012) 0.75